Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2S)-2-(3-carbamimidamidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the IUPAC name 2-{3-[(diaminomethylidene)amino]phenyl}-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid. It contains a guanidine group attached to a phenylene ring, and a phosphonate moiety linked to a hydroxy-substituted phenylalkane side chain. The drug is classified as experimental and does not have an approved therapeutic indication or established clinical use. Its mechanism of action, pharmacological target(s), and potential indications are not described in public databases, suggesting it may be an investigational tool compound or early-stage lead structure[7][10].
- Other names
- (2S)-2-(3-Carbamimidamidamidophenyl)-3-(hydroxy(3-phenylpropyl)phosphoryl)propanoic acid2-(3-((diaminomethylidene)amino)phenyl)-3-(hydroxy(3-phenylpropyl)phosphoryl)propanoic acid2-{3-[(diaminomethylidene)amino]phenyl}-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid
Beyond the preview
Go deeper on (2S)-2-(3-carbamimidamidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2S)-2-(3-carbamimidamidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid.